Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.

MLA

Schett G, et al. “Tumor Necrosis Factor Alpha and RANKL Blockade Cannot Halt Bony Spur Formation in Experimental Inflammatory Arthritis.” Arthritis & Rheumatism, vol. 60, no. 9, Sept. 2009, pp. 2644–54. EBSCOhost, https://doi.org/10.1002/art.24767.

APA

Schett G, Stolina M, Dwyer D, Zack D, Uderhardt S, Krönke G, Kostenuik P, & Feige U. (2009). Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. Arthritis & Rheumatism, 60(9), 2644–2654. https://doi.org/10.1002/art.24767

Chicago

Schett G, Stolina M, Dwyer D, Zack D, Uderhardt S, Krönke G, Kostenuik P, and Feige U. 2009. “Tumor Necrosis Factor Alpha and RANKL Blockade Cannot Halt Bony Spur Formation in Experimental Inflammatory Arthritis.” Arthritis & Rheumatism 60 (9): 2644–54. doi:10.1002/art.24767.